More recently, GLP-1 medications have been recognized for supporting weight management and addressing metabolic issues
Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist originally developed to treat type 2 diabetes
Specifically, this action on the metabolism of long-chain fatty acids, through the help of many enzymes, including Carnitine-acyltransferase, modulates their concentration at the level of the mitochondria where they are then used to produce energy
Which method wins here really comes down to your personality: if you are disciplined and dislike needles, pills may suit you
This is the second trial of the drug that failed to meet trial the company and analysts expectations of a 25% average weight loss.
Been using this for over a year now, so I can give an honest review